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Introduction
Pyrrolizidine alkaloids (PAs) are a type of defense constituents with similar chemical structure and wildly present in plants. PAs have been attracting attention due to their severe hepatotoxicity and wide range of sources placing humans at a high risk for exposure. Approximately 3% of flowering plants contain toxic PAs, and 660 kinds of PAs and their N-oxide metabolites have been found in more than 6000 plants in worldwide (Radominska-Pandya 2010; Smith and Culvenor, 1981) .
Many foodstuffs, such as milk, honey, eggs, tea and plant spices were reportedly contaminated by PAs (Huybrechts and Callebaut, 2015) . Research showed that unsaturated PAs exhibited notable toxicity after metabolic activation mainly by cytochrome P450 (CYP)
3A to form electrophilic intermediates (pyrrolic esters), which attack a variety of important intracellular nucleophilic substances (e.g. DNA and protein) (Ruan et al. 2015; Yang et al. 2001) . Pyrrolic esters can be detoxified by conjugating with glutathione (GSH), and excessive PA exposure may cause depletion of GSH and adduction of DNA and protein, lead to hepatocyte apoptosis and death, and result in hemorrhagic necrosis, liver macrocytosis and vein occlusion (Zhou et al. 2007 ).
Besides hepatic damage, PAs can also cause embryo toxicity. Hepatic sinusoidal obstruction syndrome was observed in a newborn infant from a mother who drank herbal tea during gestation, and the tea was found to contain detectable level of PA seconine (Roulet et al. 1988) . Animal studies reported fetal deaths, weight loss, and teratogenesis in pregnant rats receiving PAs from early pregnancy (Bhattacharyya 1965; Panter et al. 1998; Medeiros et al. 2000) . Our early work demonstrated that prenatal exposure to PAs alone or with lipopolysaccharide led to fetal mortality and preterm in This article has not been copyedited and formatted. The final version may differ from this version. mice (Guo et al. 2013) . But many aspects of PA-induced embryo toxicity still remain unclear. For instance, PAs are presumed to enter fetal blood circulation through placental barrier and associate with embryo toxicity, however, no experimental evidence is available up to date (Sundareson 1942 ).
In addition, although early research showed that human placenta expressed CYPs 2C, 2D6 and 3A7 during pregnancy (Hakkola et al. 1996a) , and rat placenta also contained a variety of CYP isoforms, such as CYP3A1 (Ejiri et al. 2003) , whether CYP3A protein in placenta has function to catalyze xenobiotics metabolism is controversial (Hakkola et al. 1996; Maezawa et al. 2010; Fabian et al. 2016 ). Most importantly, whether fetal liver has the ability to metabolize PAs needs to be verified, so that we can evaluate the contribution of fetal metabolism to PA-induced embryotoxicity. Although it has been reported that hepatic CYP3A protein was detectable in both human and rat fetuses (Wyde et al. 2005; Hines, 2008) , there was still lack of evidence that toxic metabolites of PAs can be produced by fetal liver.
Furthermore, hepatotoxicity of PAs was reported to show gender difference. Lin and coworkers found that metabolic activation of clivorine, a naturally occurring pyrrolizidine alkaloid, took place more in adult male rats than in female (Lin et al. 2002 (Lin et al. , 2003 (Lin et al. , 2007 , which indicates that male rats may be more susceptible to PA-induced toxicity. In fetus, androgens secreted by developing testis may induce gender-specific patterns of metabolic enzyme activity in liver (O'Shaughnessy 2011). As such, we assumed that PA metabolism in fetal liver might also exhibit a gender difference.
controlled temperature (20 ± 2 °C) room. All animal experimental procedures were performed in accordance with the Guidelines for the Care and Use of Laboratory Animals of the Chinese Animal Welfare Committee.
Two female rats were mated with one male overnight (from 7:00 pm to 7:00 am next morning). The day when a vaginal plug was found was designated as gestation day 0 (GD0). Half of dams without any treatment were sacrificed on GD20, maternal liver, fetal liver and placenta were harvested for microsomes preparation through multistep centrifugation (200 g for 20 min, 9,000 g for 20 min, and 10,500 g for 1 h).
The microsomes were stored in -80 ℃ for further basal metabolism assay and enzyme kinetic study.
The other half of the pregnant rats were intragastrically given vehicle or RTS at various doses from GD9 to GD20. Animals in control group were treated with vehicle.
Rats in groups RTS5, RTS10, and RTS20 were administrated with RTS at 5, 10, or 20 mg/kg, once per day, respectively. RTS was suspended in water, followed by dropwise addition of dilute HCl solution until the alkaloids were dissolved. The resulting acidic solution was neutralized by addition of a NaOH solution. All the dams were euthanized by ether anesthesia or decapitation on GD20, 2 h after retrorsine administration. Pup body weights were recorded, and simultaneously, maternal and fetal serum and livers as well as placenta were collected for further analysis.
Morphological Examination
For retrorsine-treated rats, maternal and fetal livers as well as placenta were fixed with 10% neutral formalin. Paraffin sections (the thickness was 5 m) were prepared and then stained with hematoxylin and eosin (HE). Histomorphological changes of these tissues were evaluated under light microscopy, and photomicrographs were captured using Photo Imaging System (Nikon, TE2000). The tissue slides were obtained from at least three dams per group, and the results were verified independently by four authors (Xia Li, Jinyuan Luo, Yu Guo and Li Zhang, and Li Zhang is a pathologist with expertise in morphological examination).
Determination of Serum RTS in Dams and Fetuses
Serum levels of RTS were estimated by a reported method with some modification described by our laboratory (Yang et al. 2017) . Aliquots (20 L) of serum sample were mixed with 50 L of acetonitrile containing monocrotaline as the internal standard.
The resulting mixtures were vortex-mixed and centrifuged at 16,000 g for 10 min to remove the precipitated protein. The resultant supernatants were diluted with three volumes of water and then subjected to an LC-MS/MS system for analysis.
Determination of Pyrrole-protein Adduction in Livers of Maternal and Fetal

Rats
Liver tissues (0.2 g) were homogenized in 2 mL of phosphate buffer (pH 7.4, 100 mM), followed by centrifuging at 9,000 g for 10 min. The supernatants were used for the determination of hepatic protein adduction levels by the method established in our laboratory (Lin G et al. 2011) . Briefly, each liver sample (100 L) was mixed with 500 L of acetone, vortexed, and centrifuged at 900 g for 5 min. After being washed with 500 L of absolute ethanol, the resulting pellets were reconstituted in 500 L of freshly prepared 2% silver nitrate ethanol solution containing 5% trifluoroacetic acid and were shaken for 30 min at room temperature. After centrifugation at 19,000 g for 10 min, the resulting supernatants were reacted with 4-dimethylaminobenzaldehyde (v/v 4:1) in ethanol containing 1% perchloric acid at 55 °C for 10 min. To each sample was added 10 L of IS (diazepam, 1.25 g/mL) and the resultant mixtures were injected into an LC−MS/MS system for analysis. The chemical structure of the molecule (compound 10) detected by LC-MS/MS is shown in Scheme 1.
Enzyme Kinetic Study
The preparation of rat liver and placenta microsomes were carried out as described by our laboratory (Lin G et al. 2007) . For enzyme kinetic studies, the incubation mixtures consisted of 0.25 mg/mL microsomal protein (including maternal and fetal rat liver microsomes and placenta microsomes), 3.2 mM MgCl2, 10 mM GSH, 100 mM potassium phosphate buffer (pH 7.4), RTS (100-8,000 M) and 1.0 mM NADPH. 
LC-MS/MS Method
The quantifications of RTS and its metabolite were performed on an AB SCIEX Instruments 5500 triple quadrupole mass spectrometry (Applied Biosystems, Foster City, CA) equipped with an Agilent 1260 Series Rapid Resolution LC system. Data were analyzed using Applied Biosystems/SCIEX Analyst software (version 1.6.2).
Samples were analyzed by multiple-reaction monitoring (MRM) scanning in positive ion mode. The optimized MS instrument parameters were as follows: ion spray voltage was set at 5500 V, and ion source temperature was set at 650 °C. Curtain gas, gas 1, and gas 2 were 20, 50, and 50 psi, respectively. The characteristics of ion pairs (declustering potential, DP; collision energy, CE; and collision cell exit potential, CXP) and respective LC conditions were listed as follows.
For analysis of RTS, the chromatographic separation was achieved on a Kinetex HILIC (50×2.1 mm, 2.6 m) column (Phenomenex, Torrance, CA) protected by a Security-Guard (4.0×3.0 mm, 5.0 m) C18 column (Phenomenex, Torrance, CA).
Mobile phase was composed of acetonitrile (A)/ammonium acetate (5 mM, B) with a gradient elution as follows: 0-3.5 min, 15 % B; 3.5-4.5 min, 15-60 % B; 4.5-5.5 min, 60 % B; 5.5-6.5 min, 60-15 % B; 6.5-11 min, 15 % B. Flow rate was set at 0.4 mL/min.
The characteristic ion pair (DP, CE, and CXP) for RTS and monocrotaline (IS) were m/z 352.1→119.9 (100, 48, 10) and m/z 326.1→120.2 (270, 34, 13).
For analysis of pyrrole-protein adduction, the chromatographic separations were 
Western Blot
Protein extraction from retrorsine-treated fetal liver was carried out as described in protocol of kit (Beyotime Biotechnology, Nantong, Jiangsu, China), and maternal liver microsomes were used as the positive control. Protein extracts were separated in 5%-10% SDS-PAGE and electrophoretically transferred onto polyvinylidene fluoride membranes. After blocking with 5% nonfat milk in phosphate buffer, CYP3A proteins were determined by immunoblot using goat anti-CYP3A antibody, and GAPDH proteins were determined as housekeeping proteins employing mouse anti-GAPDH antibody. Membranes were then incubated with secondary antibodies conjugated with horseradish peroxidase, and specific protein bands were visualized by chemiluminescence detection, according to the manufacturer's protocol (Bridgen, Beijing, China).
Statistical Analysis
The data were analyzed using Statistical 
Results
Basal Metabolism of RTS in Rat Maternal-placental-fetal Unit in vitro
RTS was metabolized to a pyrrolic ester via oxidation reaction catalyzed by P450 enzymes, and the reactive metabolite sequentially reacted with GSH to form the corresponding GSH conjugates, and the formation of the GSH conjugates most likely represented the generation of the pyrrolic ester. As shown in Figure 1 , microsomes of normal maternal and fetal livers as well as placenta were able to catalyze the metabolic activation of RTS, but the efficacies varied. Significantly higher metabolic activation of RTS was observed in maternal liver microsomes than that of the microsomes obtained from fetal liver and placenta (P<0.01), while there was no distinct difference in the formation of pyrrole-GSH conjugates in fetal liver and placenta microsomes incubated with RTS.
Efficiency to Bioactivate RTS in Maternal and Fetal Liver Microsomes
Michalis-Menten plots and enzyme kinetic parameters are shown in Figure 2 for biotransformation of RTS in normal maternal and fetal livers. Km and Vmax values were calculated based on the production of GSH conjugates 4 and 5 (integrated). Vmax value was greater in maternal liver microsomes than that in fetal liver microsomes, and Km value of maternal liver microsomes was much less than that of liver microsomes prepared from pups. Maternal hepatic CLint, calculated by Vmax/Km, was 21.9-fold higher than that of female fetal liver microsomes, and was 10.8-fold higher than that of male fetal liver microsomes, respectively. Besides, male fetal microsomes exhibited a better catalytic activity than female to bioactivate RTS. 
Levels of RTS in Rat Maternal and Fetal Serum
Elevated serum RTS was observed in both dams and fetuses with the increase of dosing. The level of RTS in fetal sera was proportional to that in maternal sera, and there was no difference in serum RTS between two genders of pups ( Figure 5 ). It suggests that most RTS circulated in maternal blood permeated rat placenta and entered fetal blood flow.
Pyrrole-protein Adduction in Maternal-placental-fetal Unit in vivo
The levels of hepatic pyrrole-protein adduction in mice given RTS were assessed by chemical derivatization of the protein adducts to compound 10 (Scheme 1). As shown in Figure 6 , pyrrole-protein adduction was detected in maternal and fetal liver as well as placenta from dams administered with RTS. The contents of pyrrole-protein adducts formed in placenta of female pups were about 36.7%, 45.2% and 69.9% of maternal hepatic pyrrole protein adduction in groups 5.0, 10 and 20 mg/kg, respectively.
The levels of pyrrole-protein adduction in male fetal placenta were similar to that in placenta of female pups. There was no gender difference of placental pyrrole protein adduct content.
RTS-induced protein adduction in fetal liver was much less than that in maternal liver and placenta. Although fetal hepatic pyrrole-protein adduction increased in a dose-dependent manner, the levels of pyrrole-protein adduction in female and male pups exposed to RTS at 20 mg/kg were only 9.0% and 4.8% of maternal hepatic pyrroleprotein adduction, respectively (P<0.01). According to two-way ANOVA analysis, there was no interaction between gender and RTS treatment, but there was a significant gender difference of pyrrole-protein adduction content in fetal liver. The levels of pyrrole-protein adduction in female fetal liver were higher than that in male fetal liver (P<0.01).
This article has not been copyedited and formatted. The final version may differ from this version. 
Effect of RTS Treatment on CYP3A Expression in Fetal Liver
Expression of hepatic CYP3A was higher in male fetuses than that in female pups from dams treated with vehicle (P<0.01, Figure 7 ). There was an interaction between fetal gender and RTS treatment. Prenatal RTS exposure significantly induced CYP3A expression in female fetal liver (P<0.01), while down-regulated CYP3A protein content was observed in male fetal liver (P<0.01).
Discussion
Early study demonstrated that CYP3A enzyme was responsible for metabolic activation of RTS (Wang et al. 2005) . To determine the role of fetal hepatic and placental CYP3A in bioactivation of RTS and RTS-induced fetal toxicity, we assessed the basal metabolic activity of CYP3A in fetal liver and placenta obtained from normal pregnant rats on GD 20. It is evident that rat fetal liver and placenta were capable of catalyzing RTS metabolism (Figure 1 ), though the basal catalytic efficiency of fetal CYP3A was lower than that in maternal liver. In addition, the results showed that basal metabolic efficiency of RTS in male fetal liver were higher than that in female, which is consistent with previous report of gender-difference in CYP3A expression and PA metabolic activation in adult rats (Lin et al. 2002 (Lin et al. , 2003 (Lin et al. , 2007 .
To better understand the relationship between RTS-induced fetal toxicity and in situ RTS metabolic activation in placenta and fetal liver, we established a prenatal-RTS-exposure rat model, and started with the investigation of changes in fetal body weight as well as in hepatic and placental morphology in prenatal RTS-exposed rats.
Prenatal exposure to RTS at 20 mg/kg during second and third trimester led to a reduction of rat fetal body weight, which verifies previous reports that PA induced developmental retardation in rats (Medeiros et al. 2000; Sandini et al. 2014; Peterson and Jago, 1982) . Remarkable paramorphia of placental trophoblast and fetal hepatocytes were observed in animals treated with RTS at 20 mg/kg (Figure 4 ).
Developing liver appeared to be more susceptible to this reactive hepatotoxicant, manifested by significant pathological changes of fetal liver but slightly swelling of maternal hepatocyte (Figure 4 ). Then we examined the parent RTS and pyrroleprotein adduction in utero. It has been speculated that PA was able to permeate placenta (Sundareson 1942) , but no experimental evidence was available in support of the speculation until our study. The level of RTS in fetal sera was similar as that in mother sera, especially for high dose group ( Figure 5 ). Barrier role of ATP-binding cassette (ABC) transporters, especially P-glycoprotein, in placenta was stressed by
Lankas and his colleagues (Lankas et al. 1998 ), but Tu et al. reported that RTS is a weak substrate for P-glycoprotein (Tu et al. 2014) . We guess that may be the reason why RTS entered rat fetus through placenta barrier almost without obstacle.
Pyrrolic esters are the main toxic metabolites of PAs. Because of their electrophilic reactivity, pyrrolic esters attack nucleophilic sites of protein to form pyrrole protein adduction after generated from parent PAs in situ, and the protein modification may trigger the hepatotoxicity of PAs. A considerable amount of pyrrole protein adducts was observed in placenta in rats prenatally exposed to RTS. Although we confirmed metabolic activation of RTS in placenta in vitro, we cannot exclude the possibility that the reactive metabolite of RTS generated in maternal liver can be transported to placenta with blood flow and then exerted their toxicity by reacting with protein in placenta. The reason for this speculation is that pyrrolic ester-derived GSH conjugate in placental microsomes was found to be only 10% of that in maternal liver microsomes in vitro, while similar levels of pyrrole-protein adduction were found in placenta and maternal liver in vivo. It suggests that the reactive metabolite of RTS formed through maternal bioactivation probably participated, at least in part, in the Pyrrole-protein adduction took place less in fetal liver than those in maternal liver and placenta in animals given RTS (Figure 6 ). However, minor changes in histopathology were observed in maternal liver tissues. The explanation could be that developing embryo has relatively low levels of CYP3A, which leads to the lower amount of pyrrole-protein adduction observed in fetal liver. Some critical detoxifying enzymes, such as glutathione S-transferases, are also much less in fetal than that in mother liver (Wells et al., 2009) . And activities of most antioxidative enzymes in embryonic liver are only around 5% of that in maternal liver (Wells et al., 2005) . In addition, fetuses are more susceptible to genetic damage than adults. After exposure to tobacco smoke for 20 days, fetuses showed greater DNA damage than the dams (Florek et al., 1999) . The above factors may contribute to the high susceptibility of fetus to reactive intermediate-mediated toxicity such as RTS-induced liver injury.
Local metabolic activation seems to be the primary cause of RTS-induced fetal liver toxicity. Juchau and coworkers mentioned that exported reactive intermediates generated from maternal liver were unlikely to reach embryonic targets and were impossible to pass through chorioallantoic and/or yolk sac membranes from maternal systemic circulation (Juchau et al. 1989) . The present study clearly demonstrated a weak but certain RTS metabolism in normal fetal liver. The weak basal metabolic activation of RTS by fetal liver microsomes in vitro is in agreement with the low level of pyrrole protein adduct generation in pup liver in vivo. Since pyrrole protein adduct is a definite marker for PA toxicity (Gao et al. 2015; Ruan et al. 2015; Xia et al. 2016 ), In normal physiological condition, CYP3A expression in male liver is higher than female, both for adult (Lin et al. 2002 (Lin et al. , 2003 (Lin et al. , 2007 and fetal rats (Figure 7) . In summary, the present study examined the metabolic activity of RTS in maternal-placental-fetal unit in vitro, and evaluated embryo toxicity and fetal local metabolic activation of the PA in vivo. The main conclusions included the following points: 1) rat fetal liver and placenta was capable to metabolize RTS; 2) prenatal exposure to RTS caused remarkable organ/tissue injury and loss of fetal body weight;
3) RTS almost permeated "placenta barrier" completely, but the levels of the resulting pyrrole-protein adduction varied in maternal liver, fetal liver, and placenta; 4) more pyrrole-protein adduction took place in female pups than in male；and 5) the observed female-specific metabolic activation of RTS may arise from higher CYP3A expression in female fetal liver, induced by long-term exposure to PAs. This article has not been copyedited and formatted. The final version may differ from this version. 
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